Inactive Instrument
Cellivery Therapeutics, Inc. Stock
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 2014-08-27 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 2019-03-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 2014-08-27 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 2023-03-30 |
Hyung Kim
BRD | Director/Board Member | 40 | 2024-03-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 400K | |
| +3.41% | -0.10% | +72.88% | +128.53% | 55.78B | |
| +6.76% | +18.10% | +91.66% | +104.09% | 55.66B | |
| +3.33% | +4.51% | -11.68% | -11.91% | 23.84B | |
| +1.32% | +6.22% | +5.28% | +415.45% | 22.7B | |
| +7.88% | +8.46% | +40.91% | -28.18% | 16.12B | |
| -0.89% | +5.71% | +24.30% | +186.29% | 13.64B | |
| +9.96% | +15.98% | +157.65% | +310.89% | 14.8B | |
| +2.85% | +2.81% | +75.32% | +139.44% | 12.16B | |
| +6.17% | +10.22% | +163.15% | +166.44% | 11.85B | |
| Average | +1.03% | +7.40% | +68.83% | +156.78% | 25.17B | |
| Weighted average by Cap. | +4.62% | +7.70% | +67.01% | +143.31% |
Employees
4
